Alphabet Inc.
CIK 1652044 · last filed 2025-02-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CRWD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MOUNTAIN VIEW, CA 94043
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OSCR | 10%+ Owner | 255,092 | $30.79 | $7.85M | -$472.74M | 1 | 2023-08-21 |
| GOOGL | 10%+ Owner | 0 | $283.82 | $0 | -$52.53M | 1 | 2023-08-21 |
| PRME | 10%+ Owner | 10,229,657 | $5.24 | $53.60M | -$17.02M | 2 | 2023-06-15 |
| GTLB | 2,647,312 | $56.65 | $149.97M | $112.71M | 5 | 2023-05-09 | |
| Verve Therapeutics, Inc. (VERV) Delisted | 0 | $11.13 | $0 | -$37.17M | 1 | 2022-11-04 | |
| DUOL | 10%+ Owner | 91,565 | $136.39 | $12.49M | -$109.76M | 2 | 2022-02-10 |
| FRSH | 10%+ Owner | 2,094,204 | $15.01 | $31.43M | -$5.29M | 1 | 2021-11-23 |
| CRWD | 10%+ Owner | 9,398,840 | $261.15 | $2.45B | -$750.24M | 3 | 2020-01-03 |
| RCUS | 10%+ Owner | 1,924,474 | $18.61 | $35.81M | $0 | 1 | 2018-03-19 |
| ARMO BioSciences, Inc. (ARMO) Delisted | 10%+ Owner | 607,350 | — | — | $0 | 2 | 2018-01-30 |
Recent Filings · Page 2 of 2
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-16 | GTLB | Buy (P) | +96,172 | $3.20M | EDGAR |
| 2022-02-10 | DUOL | Sell (S) | −222,318 | -$27.31M | EDGAR |
| 2022-02-10 | DUOL | Sell (S) | −619,980 | -$82.46M | EDGAR |
| 2021-11-23 | FRSH | Sell (S) | −136,420 | -$5.29M | EDGAR |
| 2020-01-03 | CRWD | Mixed | — | -$737.02M | EDGAR |
| 2019-12-11 | CRWD | Mixed | — | -$37.02M | EDGAR |
| 2019-06-18 | CRWD | Mixed | +700,000 | $23.80M | EDGAR |
| 2018-03-19 | RCUS | Conv (C) | +7,697,896 | $0 | EDGAR |
| 2018-01-30 | ARMO BioSciences, Inc. (ARMO) Delisted | Conv (C) | +2,429,400 | $0 | EDGAR |
| 2018-01-30 | ARMO BioSciences, Inc. (ARMO) Delisted | Conv (C) | +1,822,050 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.